Abstract
Penicillin allergy status has an overall negative impact on patient health. Active de-labeling has been shown to improve healthcare outcomes. We assessed the risk of developing penicillin allergy among patients using proton pump inhibitors (PPI)s or histamine-2 receptor antagonists (HR2A)s as examples of potentially modifiable risk factors.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
